A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features

The atypical neuropathological features observed, which are reminiscent of those observed for the G51D aSyn variant, suggest a causal role of the SNCA variant with a distinct clinical and pathological phenotype, which is further supported by the properties of the mutant aSyn.

Authors

Institutions

Publication Details

Journal
Molecular Neurodegeneration
Published
2025-09-26
DOI
https://doi.org/10.1186/s13024-025-00889-y
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features

Nagendran Ramalingam, Michael Zech, Mohammed Al‐Azzani, Susana R. Chaves et al.
Molecular Neurodegeneration
Parkinson's Disease Mechanisms and Treatments
article

A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features

Nagendran Ramalingam, Michael Zech, Mohammed Al‐Azzani, Susana R. Chaves, Claudio O. Fernández, Alexander Zimprich, Fiamma A. Buratti, Markus Zweckstetter, Ulf Dettmer, Aswathy Chandran, Janin Lautenschläger, Ellen Gelpí, Rubén Fernández‐Busnadiego, Aishwarya Agarwal, Maria Ramón, Christof Brücke, Tiago Fleming Outeiro, Kevin Sicking, Leslie Amaral, Rita L. Sousa
article en

Abstract

The atypical neuropathological features observed, which are reminiscent of those observed for the G51D aSyn variant, suggest a causal role of the SNCA variant with a distinct clinical and pathological phenotype, which is further supported by the properties of the mutant aSyn.

Molecular NeurodegenerationVol. 20(1)
Brigham and Women's Hospital (US), German Center for Neurodegenerative Diseases (DE), Helmholtz Zentrum München (DE), National University of Rosario (AR), Cambridge School (PT), Universitätsmedizin Göttingen (DE), Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103 (DE), Max Planck Institute for Biophysical Chemistry (DE), Max Planck Institute of Experimental Medicine (DE), Research Network (United States) (US), Max Planck Institute for Multidisciplinary Sciences (DE), Technical University of Munich (DE), University of Göttingen (DE), Medical University of Vienna (AT), Newcastle University (GB), University of Minho (PT)
Michael J. Fox Foundation for Parkinson's Research, Australian Government, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Else Kröner-Fresenius-Stiftung, Technische Universität München, National Institutes of Health
Openalex Percentile: Top 62%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.